Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.32)
# 949
Out of 4,760 analysts
446
Total ratings
36.88%
Success rate
4.98%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OBIO Orchestra BioMed Holdings | Reiterates: Buy | $14 | $3.97 | +252.64% | 3 | Mar 10, 2025 | |
| CLSD Clearside Biomedical | Reiterates: Buy | $6 | $0.88 | +581.97% | 19 | Mar 6, 2025 | |
| EYPT EyePoint Pharmaceuticals | Reiterates: Buy | $22 | $7.09 | +210.30% | 21 | Mar 6, 2025 | |
| BLFS BioLife Solutions | Maintains: Buy | $27 → $30 | $24.86 | +20.68% | 1 | Mar 6, 2025 | |
| OCUL Ocular Therapeutix | Reiterates: Buy | $15 | $7.65 | +96.08% | 26 | Mar 4, 2025 | |
| OPK OPKO Health | Reiterates: Buy | $3 | $1.84 | +63.04% | 11 | Mar 3, 2025 | |
| CDNA CareDx | Maintains: Neutral | $26 → $25 | $18.09 | +38.20% | 11 | Mar 3, 2025 | |
| BLCO Bausch + Lomb | Maintains: Buy | $23 → $20 | $15.90 | +25.79% | 17 | Feb 21, 2025 | |
| ANIX Anixa Biosciences | Reiterates: Buy | $7 | $2.63 | +166.16% | 18 | Feb 18, 2025 | |
| OKYO OKYO Pharma | Reiterates: Buy | $7 | $1.36 | +414.71% | 12 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $6.78 | +121.24% | 20 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $11.61 | +227.30% | 7 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $12 | $4.35 | +175.86% | 18 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $22.22 | +156.53% | 1 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $1.34 | +422.39% | 5 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $31.42 | +59.13% | 2 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $6.01 | +499.00% | 8 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3 | $0.96 | +212.50% | 12 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $8.37 | +79.21% | 9 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $18.30 | +63.93% | 12 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.50 | +500.00% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $14.65 | +234.47% | 5 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $7.17 | +137.10% | 20 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $1.29 | +93.80% | 19 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.91 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.63 | +242.21% | 16 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $100 | $66.95 | +49.37% | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.19 | +213.48% | 15 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $4.27 | +181.03% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $1.5 | $0.54 | +180.37% | 22 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.04 | +188.46% | 1 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $1.5 | $0.14 | +979.91% | 18 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.33 | +2,930.30% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.38 | +2,790.17% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.77 | - | 7 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $16.05 | +199.07% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $640 | $1.56 | +41,044.33% | 5 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $10.23 | +85.73% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.28 | - | 2 | Apr 16, 2020 |
Orchestra BioMed Holdings
Mar 10, 2025
Reiterates: Buy
Price Target: $14
Current: $3.97
Upside: +252.64%
Clearside Biomedical
Mar 6, 2025
Reiterates: Buy
Price Target: $6
Current: $0.88
Upside: +581.97%
EyePoint Pharmaceuticals
Mar 6, 2025
Reiterates: Buy
Price Target: $22
Current: $7.09
Upside: +210.30%
BioLife Solutions
Mar 6, 2025
Maintains: Buy
Price Target: $27 → $30
Current: $24.86
Upside: +20.68%
Ocular Therapeutix
Mar 4, 2025
Reiterates: Buy
Price Target: $15
Current: $7.65
Upside: +96.08%
OPKO Health
Mar 3, 2025
Reiterates: Buy
Price Target: $3
Current: $1.84
Upside: +63.04%
CareDx
Mar 3, 2025
Maintains: Neutral
Price Target: $26 → $25
Current: $18.09
Upside: +38.20%
Bausch + Lomb
Feb 21, 2025
Maintains: Buy
Price Target: $23 → $20
Current: $15.90
Upside: +25.79%
Anixa Biosciences
Feb 18, 2025
Reiterates: Buy
Price Target: $7
Current: $2.63
Upside: +166.16%
OKYO Pharma
Feb 18, 2025
Reiterates: Buy
Price Target: $7
Current: $1.36
Upside: +414.71%
Feb 13, 2025
Reiterates: Buy
Price Target: $15
Current: $6.78
Upside: +121.24%
Feb 11, 2025
Reiterates: Buy
Price Target: $38
Current: $11.61
Upside: +227.30%
Feb 10, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $4.35
Upside: +175.86%
Feb 6, 2025
Initiates: Buy
Price Target: $57
Current: $22.22
Upside: +156.53%
Jan 24, 2025
Maintains: Buy
Price Target: $10 → $7
Current: $1.34
Upside: +422.39%
Jan 23, 2025
Reiterates: Buy
Price Target: $50
Current: $31.42
Upside: +59.13%
Jan 15, 2025
Reiterates: Buy
Price Target: $36
Current: $6.01
Upside: +499.00%
Jan 13, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.96
Upside: +212.50%
Jan 10, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $8.37
Upside: +79.21%
Jan 6, 2025
Reiterates: Buy
Price Target: $30
Current: $18.30
Upside: +63.93%
Jan 2, 2025
Reiterates: Buy
Price Target: $3
Current: $0.50
Upside: +500.00%
Dec 11, 2024
Reiterates: Buy
Price Target: $49
Current: $14.65
Upside: +234.47%
Dec 6, 2024
Reiterates: Buy
Price Target: $17
Current: $7.17
Upside: +137.10%
Nov 27, 2024
Reiterates: Buy
Price Target: $2.5
Current: $1.29
Upside: +93.80%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.91
Upside: -
Nov 22, 2024
Reiterates: Buy
Price Target: $9
Current: $2.63
Upside: +242.21%
Nov 13, 2024
Maintains: Buy
Price Target: $60 → $100
Current: $66.95
Upside: +49.37%
Nov 12, 2024
Reiterates: Buy
Price Target: $10
Current: $3.19
Upside: +213.48%
Nov 11, 2024
Reiterates: Buy
Price Target: $12
Current: $4.27
Upside: +181.03%
Nov 11, 2024
Reiterates: Neutral
Price Target: $1.5
Current: $0.54
Upside: +180.37%
Nov 7, 2024
Initiates: Buy
Price Target: $3
Current: $1.04
Upside: +188.46%
Jun 10, 2024
Maintains: Buy
Price Target: $7 → $1.5
Current: $0.14
Upside: +979.91%
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $0.33
Upside: +2,930.30%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.38
Upside: +2,790.17%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.77
Upside: -
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $16.05
Upside: +199.07%
Apr 1, 2021
Maintains: Buy
Price Target: $480 → $640
Current: $1.56
Upside: +41,044.33%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $10.23
Upside: +85.73%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.28
Upside: -